Logo CICANCER

Novel targeted therapies in lymphoid neoplasia: from apoptosis activation to microenvironment harnessing

Novel targeted therapies in lymphoid neoplasia: from apoptosis activation to microenvironment harnessing

Patricia Pérez Galán

IDIBAPS- Hospital Clinic, Barcelona

Date: 02/05/2019
Time: 12:00:00
Salón de actos del Centro de Investigación del Cáncer

In the last years  it has been acknowledge that the origin of most of lymphoid neoplasia derives from a tight collaboration between specific genetic alterations and the support of the accompanying non-tumor cells, the so- called tumor microenvironment. A potentially effective treatment must attack tumor cells with targeted therapies and, at the same time, dismantle the 'contact network' that protects it, that is, the microenvironment. In this seminar we will